Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$161.97 USD

161.97
575,208

+1.87 (1.17%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $161.95 -0.02 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 6% (16 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

BD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite

by Zacks Equity Research

BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.

Philips (PHG) Boosts Precision Diagnosis With AI Platform

by Zacks Equity Research

Philips (PHG) boosts its Precision Diagnosis portfolio with an AI-powered ultrasound platform, strengthening its Diagnosis & Treatment segment.

Sanghamitra Saha headshot

Play Likely Earnings Beat With These 5 Top-Ranked Stocks

by Sanghamitra Saha

Top-ranked stocks MGM Resorts International (MGM), Burlington Stores (BURL), Sterling Infrastructure Inc (STRL), Dropbox (DBX) and DaVita (DVA) are likely to beat on the bottom line in their upcoming releases.

Waters (WAT) Expands Mass Spectrometer Portfolio With Xevo MRT

by Zacks Equity Research

Waters (WAT) boosts MS offerings with the launch of Xevo MRT, strengthening its Waters operating segment's portfolio.

Three Reasons to Retain BD (BDX) Stock in Your Portfolio Now

by Zacks Equity Research

BD's (BDX) robust product portfolio raises optimism about the stock.

Patterson Companies' (PDCO) New Launch to Boost Patient Service

by Zacks Equity Research

Patterson Companies' (PDCO) Patterson CarePay+ is likely to improve overall patient care and streamline practice operations.

DaVita (DVA) Hits 52-Week High: What's Aiding the Stock?

by Zacks Equity Research

Investors are optimistic about DaVita's (DVA) strength in kidney care.

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now

by Zacks Equity Research

Revvity's (RVTY) strong product portfolio raises optimism about the stock.

Reasons Why You Should Retain Avantor (AVTR) Stock for Now

by Zacks Equity Research

Avantor's (AVTR) strong product portfolio raises optimism about the stock.

DaVita Inc. (DVA) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Philips (PHG) Boosts Medical Imaging Footprint With New Move

by Zacks Equity Research

Philips (PHG) expands its international footprint with the wide availability of VeriSight Pro 3D to several Hong Kong hospitals, strengthening its Diagnosis & Treatment segment.

Reasons to Retain Baxter International (BAX) in Your Portfolio Now

by Zacks Equity Research

Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.

Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now

by Zacks Equity Research

Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. Gross margins improve. However, the rising cost of products is a concern.

Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now

by Zacks Equity Research

Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Is BellRing Brands (BRBR) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how BellRing Brands (BRBR) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.

Centene (CNC), Cityblock Partner to Enhance Value-Based Care

by Zacks Equity Research

Centene (CNC) collaborates with Cityblock to provide comprehensive care services to Central Florida's Medicaid members.

Here's Why You Should Add Ecolab (ECL) to Your Portfolio Now

by Zacks Equity Research

Ecolab's (ECL) focus on research and development raises optimism about the stock.

Philips (PHG) Strengthens Patient Monitoring Services in Spain

by Zacks Equity Research

Philips (PHG) announces the wide availability of its ambulatory cardiac monitoring service in Spain, boosting its patient monitoring solutions portfolio.

Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Intuitive Surgical (ISRG) Hits 52-Week High on Procedure Demand

by Zacks Equity Research

Intuitive Surgical's (ISRG) da Vinci procedure volume, coupled with strong Ion procedure growth, is fueling the rally in the company???s share price.

Here's Why You Should Retain Inari Medical (NARI) for Now

by Zacks Equity Research

Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.

Three Reasons to Retain Merit Medical (MMSI) Stock for Now

by Zacks Equity Research

Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.

Merit Medical's (MMSI) Latest Launch to Boost Patient Care

by Zacks Equity Research

Merit Medical's (MMSI) latest offering is likely to create an efficient approach to inflation, thereby providing improved patient care.

Reasons to Add HealthEquity (HQY) Stock to Your Portfolio

by Zacks Equity Research

HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.